Ann: JHL executes Binding Licence Agreement with Medicann, page-70

Nothing solid in it. Take a true comparison of same periods of previous years. Share consistently trending down, Revenue consistently trending down. Expenses accelerated for no revenue return and the only thing the management has done is trim some expenses, but that only saves you for a short time. Soon or later you have to increase revenue and there is no evidence of that happening with the market for appointment management, engagement, kiosks, scripts all saturated by its competitors, e.g. HotDoc has more than double with greater than 20% market share in GP space and has a fresh $5M capital injection.